This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n13http://linked.opendata.cz/resource/drugbank/drug/DB07218/identifier/pubchem-substance/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB07218/identifier/drugbank/
n12http://bio2rdf.org/drugbank:
n8http://linked.opendata.cz/resource/drugbank/drug/DB07218/identifier/chemspider/
admshttp://www.w3.org/ns/adms#
n11http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n6http://linked.opendata.cz/resource/drugbank/drug/DB07218/identifier/pdb/
xsdhhttp://www.w3.org/2001/XMLSchema#
n7http://linked.opendata.cz/resource/drugbank/drug/DB07218/identifier/pubchem-compound/

Statements

Subject Item
n2:DB07218
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n11:DB07218 n12:DB07218
dcterms:title
6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE
adms:identifier
n6:73Q n7:6540289 n8:5022688 n9:DB07218 n13:99443689
n3:IUPAC-Name
n4:271B558E-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5594-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5593-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5590-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5591-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5592-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B558C-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B558A-363D-11E5-9242-09173F13E4C5 n4:271B558D-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B558B-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B559A-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B559B-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5595-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5596-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5598-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5597-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5599-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B55A0-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B55A2-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B55A3-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B559F-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B559E-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B55A1-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B558F-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B559C-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B559D-363D-11E5-9242-09173F13E4C5